Sustained virologic response in patients with genotype 3 hepatitis C virus (HCV) infection and advanced fibrosis or cirrhosis was achieved in 88% of t...
The only patients with alcoholic hepatitis to derive a survival benefit from extracorporeal hepatocellular therapy with C3A hepatoma cells were those ...
The findings are encouraging because current treatment options for patients with HCV who have decompensated liver disease are limited, Dr. Charlton no...
A triple antiviral combination with direct-acting antiviral agents was associated with high rates of sustained virologic response across all three hep...
Emricasan, a caspase inhibitor, achieves a significant reduction in portal pressure among patients with cirrhosis and severe portal hypertension, acco...
Ustekinumab, a monoclonal antibody targeted against interleukins 12 and 23 (IL-12 and IL-23), met its primary endpoint for control of Crohn’s disease ...
A survey of almost 500 physicians found that primary care physicians (PCPs) are far more concerned about the reported adverse effects of proton pump i...
A DNA-based molecular diagnostic test that stratifies pancreatic cysts for their malignant potential better than current alternatives can help guide m...
Obese patients who develop an upper GI bleed receive more treatment, are more likely to develop hemorrhagic shock, and are more likely to require admi...
